Table 5.
Characteristics of sarcoidosis patients
| Patient number | Sex | Age at diagnosis (years) | Follow up (years) | BAL lymphocytes (%) | Organs involved (biopsied organ) |
|---|---|---|---|---|---|
| 1* |
M |
6.5 |
9.4 |
42 |
Lung, lymphadenopathy |
| 2 |
M |
8.0 |
3.6 |
48 |
Lung, lymphadenopathy, eye (uveitis) |
| 3 |
F |
13.8 |
2 |
64 |
Lung, liver |
| 4 |
M |
13.5 |
3.8 |
69 |
Lung, lymphadenopathy, liver |
| 5 |
M |
12.7 |
4.2 |
28 |
Lung, lymphadenopathy |
| 6 |
F |
8.2 |
2.7 |
49 |
Lung, lymphadenopathy, bone marrow, spleen |
| 7 |
F |
7.1 |
2.4 |
30 |
Lung, lymphadenopathy, bowel |
| 8 |
F |
11.2 |
4 |
MD |
Lung, skin |
| 9 |
M |
14.4 |
3.1 |
20 |
Lung, lymphadenopathy, parotid, eye, joints |
| 10 |
M |
5.9 |
6.7 |
29 |
Lung, skin, spleen |
| 11* |
F |
9.1 |
9.1 |
59 |
Lung, lymphadenopathy, liver, eye |
| 12 |
F |
13 |
3.3 |
MD |
Lung, eye, liver, kidney, skin |
| 13 |
F |
11.5 |
2.6 |
72 |
Lung, joints, lymphadenopathy |
| 14 |
F |
10.8 |
2 |
12 |
Lung |
| 15 |
M |
12.8 |
2.5 |
18 |
Lung, liver, skin, eye, bone marrow |
| 16 |
M |
5.6 |
5.2 |
MD |
Lung, larynx, tonsils |
| 17 |
F |
14 |
4 |
MD |
Lung, joints, eye |
| 18 |
F |
9.6 |
0.8 |
23 |
Lung, liver, lymphadenopathy |
| 19 |
F |
8.3 |
0.4 |
MD |
Lung |
| 20 |
M |
9 |
9.2 |
50 |
Lung |
| 21 |
M |
9.3 |
MD |
MD |
Lung, lymphadenopathy, central nervous system |
| Total | Sex ratio 1 | Median 9.4 |
Median 3.4 |
Restricted to the lung = 3, multi-organic = 18 |
* Published patients.
Abbreviations: M: male. F: female. MD: missing data. BAL: broncho-alveolar lavage.